PharmaShots | Incisive News in 3 Shots

Subscribe Now

Agomab

Agomab’ AGMB-129 Receives the US FDA’s Fast Track Designation for Fibrostenosing Crohn’s Disease

Agomab’ AGMB-129 Receives the US FDA’s Fast Track Designation for Fibrostenosing Crohn’s Disease

October 5, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us